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ARTICLE
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ABSTRACT
OBJECTIVES.Antibiotic exposure in early life may be associated with atopic disease
development either by interfering with bacterial commensal flora or by modifying
the course of bacterial infections. We evaluated early life exposure to antibiotics
and the subsequent development of eczema, wheeze, and allergic sensitization in
infancy.
METHODS. Information on antibiotic use in the first 6 months and eczema and
wheeze until age 2 was collected by repeated questionnaires in 2764 families
participating in the KOALA (Child, Parent and Health: Lifestyle and Genetic
Constitution [in Dutch]) Birth Cohort Study in the Netherlands. Antibiotic intake
was evaluated both as maternal antibiotic use during breastfeeding and infant oral
medication. Venous blood samples taken from 815 infants at 2 years of age were
analyzed for total and specific immunoglobulin E against common food and
inhalant allergens using a radioallergosorbent test. Multivariate logistic regression
analysis was used to adjust for confounding factors.
RESULTS.During the first 2 years, eczema was present in 32% of all infants, recurrent
wheeze in 11%, and prolonged wheezing in 5%. At 2 years old, 27% of children
were sensitized against 1 allergen. At 6 months old, 11% had been exposed to
antibiotics through breast milk and 20% directly through medication. The risk for
recurrent wheeze, and prolonged wheeze was higher in infants directly exposed to
antibiotics through medication, also after excluding from the analyses children
who wheezed in the same period as an antibiotic had been used (avoiding reverse
causation). Antibiotic use through breastfeeding was associated with recurrent
wheeze, but prolonged wheeze was not. Eczema and sensitization were not
associated with antibiotic exposure.
www.pediatrics.org/cgi/doi/10.1542/
peds.2006-0896
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CONCLUSIONS.We demonstrated that early antibiotic use
preceded the manifestation of wheeze but not eczema or
allergic sensitization during the first 2 years of life. Dif-
ferent biological mechanisms may underlie the etiology
of wheeze compared with eczema or sensitization. Antibi-
otic exposure through breastfeeding enhanced the risk for
recurrent wheeze, but this needs further confirmation.
THE PREVALENCE OF atopic manifestations, which in-clude atopic eczema, allergic rhinoconjunctivitis,
and asthma, have increased worldwide, especially in
children.1,2 Symptoms are most common in western
countries but also increase in developing countries as
they become more westernized. Currently one third of
the children in western societies show symptoms.3
Many western lifestyle and medical care characteris-
tics have changed over the years and might be of interest
in relation to atopy. For example, the increased pediatric
allergy in developed countries closely followed time
trends in increased use of antibiotics among young chil-
dren. Antibiotics particularly interfere with the bacterial
commensal flora and disturb the intestinal microbiota
composition.4,5 It has been hypothesized that infections
in early life, as well as colonization of the gut, protects
against atopy.6 Consequently, antibiotic exposure in
early life may be associated with atopic disease develop-
ment either by interfering with bacterial commensal
flora or by modifying the course of bacterial infections.
Indeed, positive associations between antibiotic use
and childhood allergy and asthma have been report-
ed.7–14 The majority of these results came from cross-
sectional studies, and, in many,7,8,10–12,14 the question of
“reverse causation” remained unresolved: Did antibiotic
intake precede symptoms or were antibiotics prescribed
in response to symptoms of wheezy bronchitis? Also,
evaluation of exposure to antibiotics through breastfeed-
ing and subsequent development of atopy is lacking.
Antibiotic use is fairly common among breastfeeding
mothers,15 in particular, penicillins, for the treatment of
mastitis. Both have been detected in breast milk in small
quantities, as reviewed by Chung et al.16 Maternal use of
antibiotics is relevant with regard to transfer to the
breastfed infant.
In a large prospective birth cohort study in the Nether-
lands, we prospectively evaluated the association between
early life antibiotic exposure, both through maternal anti-
biotic use during breastfeeding and through infant oral
medication, and the subsequent development of eczema,
wheeze, and allergic sensitization in the first 2 years of life.
METHODS
Study Subjects
A detailed description of the design of our cohort has
been published previously.17 In summary, the KOALA
(Child, Parent and Health: Lifestyle and Genetic Consti-
tution [in Dutch]) Birth Cohort Study started in October
2000. Participants were recruited in the southern half of
the Netherlands from 2 sources. First, pregnant women
were recruited from an ongoing prospective cohort
study on pregnancy-related pelvic girdle pain (PPGP).18
Participants of the PPGP study were recruited via mid-
wife clinics at 14 to 16 weeks of gestation. At 34 weeks
of gestation, PPGP subjects were asked to participate in
the KOALA Study (“conventional subcohort”). Second,
to increase the number of participants with lifestyle
choices that have a low prevalence in the general pop-
ulation, pregnant women with so-called “alternative”
lifestyles were recruited through several specific recruit-
ment channels, that is, anthroposophic doctors and mid-
wives, anthroposophic under-5 clinics, Steiner Schools,
posters and flyers in organic food shops, and magazines
for special interest groups (eg, homeopathy, anthropos-
ophy, and antivaccine; “alternative subcohort”). These
women were enrolled at 14 to 18 weeks of gestation. A
total of 2834 participants were included in the KOALA
Study, of whom 2343 were through the PPGP study and
491 through the specific recruitment channels. The
study was approved by the Medical Ethical Committee of
University Maastricht/Academic Hospital Maastricht. All
of the participants had signed informed consent and
completed the first questionnaire at the third trimester
of pregnancy. Most parents (96%) were white Dutch.
Exclusion criteria in the present study were prema-
turity (gestational age 37 weeks) and congenital ab-
normalities related to immunity (such as Down syn-
drome). Three children were excluded for Down
syndrome and 67 for prematurity, resulting in 2764
participants. Of these, follow-up data were available for
93.4% (n  2598), which was 93.5% (n  2135) of the
conventional and 96.3% (n  463) of the alternative
subcohort.
From January 2004, additional funding was obtained,
and parents who were part of the second half of the
cohort (n  1301) were also asked to consent to collect-
ing venous blood from their infant at age 2 years (for the
determination of total and allergen-specific IgE-levels).
Of these, 815 (65%) signed informed consent and were
visited at home for blood sampling.
Exposure and Follow-up
All of the parents were sent detailed questionnaires
when the infants were 3, 7, 12, and 24 months of age.
Variables considered for inclusion in the multivariate
analysis were participant’s characteristics, such as the
infant’s gender, parental and siblings’ atopic history, and
number of older siblings. Positive parental atopic history
was defined as 1 self-reported doctor’s diagnoses of
asthma, pet or house dust mite allergy, hay fever, and
eczema (none, father, mother, or both). Sibship size and
siblings history of atopy (parental reports of doctor’s
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diagnosed asthma, pet or house dust mite allergy, hay
fever, eczema, and/or food allergy) were combined (no
siblings; 1 sibling, not atopic; 1 sibling, atopic; 2 sib-
lings, not atopic; and 2 siblings, 1 atopic). Other
factors included place and mode of delivery (natural
delivery at home, natural delivery in hospital, artificial
delivery in hospital [eg, delivery by vacuum or forceps
extraction], or cesarean section in hospital), breastfeed-
ing at 6 months of age (breastfeeding at 6 months old
that was exclusive at months 1–4; breastfeeding at 6
months old that was nonexclusive at months 1–4; no
breastfeeding at 6 months old but exclusive breastfeed-
ing at months 1–4; no breastfeeding at 6 months old but
nonexclusive breastfeeding at months 1–4; or never
breastfeeding), attending day care facilities in the first 6
months (yes/no), any furred pets in the first 6 months
(yes/no), exposure to environmental tobacco smoke
(ETS) in the first 6 months (yes/no), and experiencing a
period of fever (body temperature 38°C) during the
first 6 months (yes/no). Parents were asked whether
their child had been vaccinated according to the stan-
dard scheme, an “alternative vaccination scheme,” or
not at all. In the Netherlands during the time of the
study, infants in their first 6 months were standard
vaccinated against diphtheria, tetanus, pertussis (with
whole-cell pertussis vaccine), poliomyelitis, and Hae-
mophilus influenzae type B vaccine at 2, 3, and 4 months
of age. An alternative vaccination scheme was defined as
delayed vaccinations or alternative vaccine composition
(eg, omitting the pertussis component from the diphthe-
ria-pertussis-tetanus-polio vaccine).
Antibiotic use in the first 6 months postpartum was
assessed by questionnaires. Mothers were asked
whether they had used antibiotics during lactation and
whether they had completed the course. Antibiotic ex-
posure through breast milk was classified positively if a
mother completed a course of antibiotic treatment dur-
ing lactation. Parents were also asked whether their
child had used antibiotics and, if yes, for howmany days.
Direct oral antibiotic exposure was defined as positive
when the child had ever been given oral antibiotics for
3 consecutive days. No distinction was made between
different antibiotics or multiple courses of antibiotics
versus a single course in the questionnaire.
Eczema and wheeze occurrence were assessed by
questionnaires. At age 7, 12, and 24 months, parents
were asked whether their child had ever had an itchy
rash that was coming and going in the past months. If
this question was answered affirmatively at least once,
infants were classified as having developed eczema in
the first 2 years of life. Infants for whom only diaper
rash, rash around the eyes, and/or scalp scaling was
reported were not regarded as having developed eczema.
Wheeze was also asked in the 7-, 12-, and 24-month
postpartum questionnaires. “Recurrent wheeze” was de-
fined as reported presence of wheezing with 4 attacks
ever in the first 2 years. “Prolonged wheeze” was classi-
fied as ever been awake because of wheezing in both the
first and second year.
Assessment of Sensitization
Total IgE antibodies were measured by radioimmunoas-
say in serum samples as described earlier.19,20 Results
were expressed as international units of IgE per millili-
ter; 1 IU is 2.4 ng of IgE. For values 150 IU/mL, a
sandwich radioimmunoassay was used,19 and for values
150 IU/mL, a competitive radioimmunoassay was
used.20 Serum level of hen’s egg–, cow’s milk–, peanut-,
birch-, grass pollen–, cat-, dog-, and mite-specific IgE
was determined by radioallergosorbent test (RAST) as
described previously.20 Calculation was performed by
means of a standard curve that was obtained by RAST
with a dilution series of a chimeric monoclonal IgE an-
tibody against the major house dust mite allergen Der p
2 and Sepharose-coupled recombinant Der p 2.21 The
detection limit for total and specific IgE was 0.50
IU/mL and 0.13 IU/mL, respectively. We defined aller-
gic sensitization as a RAST value 0.3 IU/mL for 1
allergen and high allergic sensitization when the value
was 0.7 IU/mL.
Statistical Analysis
The relationship between antibiotic exposure and atopic
manifestations was evaluated in participants with com-
plete information on 1 of the atopic manifestations.
Missing data in the questionnaires were treated as miss-
ing in the analyses and are presented as “unknown” in
the tables. Unadjusted associations between antibiotic
exposure and atopic outcomes were examined using
logistic regression. Multivariate logistic regression mod-
els were used to control for potential confounders (gen-
der, parental history of allergy, sibling history of allergy,
number of older siblings, place and mode of delivery,
breastfeeding, day care attendance, pets, exposure to
ETS, vaccinations, and subcohort) by including them in
the regression models simultaneously. Differences in
mean total IgE levels were evaluated by means of linear
regression analyses controlling for the same confound-
ers. Analyses for determination of the effect of antibiot-
ics through breast milk were controlled for the potential
confounding effect of antibiotic exposure through oral
medication and vice versa. Some previous studies re-
ported associations between exposures and atopic out-
comes to be limited to groups with different inherited
propensity for developing atopic disease.22,23 In the mul-
tivariate analysis, therefore, we first tested the possibility
of interaction between antibiotic use and parental his-
tory of atopy. Because none of these interaction terms
were statistically significant, they were eliminated from
the regression models. Separate analyses of the conven-
tional versus alternative subcohort or boys versus girls
showed that the key findings were similar within these
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groups. Therefore, we combined all of the infants in the
final analyses, adjusting for “subcohort” and “gender.”
Results are presented as unadjusted and adjusted odds
ratios (ORs) with corresponding 95% confidence inter-
vals (CIs).
RESULTS
Study Subjects
Approximately half of infants had nonatopic parents;
one third had 1 nonatopic older sibling, and 10% had 1
atopic older sibling (Table 1). Most traditional risk factors
were equally present in both subcohorts, but in the
alternative subcohort, antibiotic exposure through med-
ication was less present than in the conventional subco-
hort. Prevalence of baseline characteristics and eczema
and wheeze manifestations did not differ between in-
fants with and without blood samples. By the age of 6
months, 262 (11%) of 2423 infants had been exposed to
antibiotics through breastfeeding and 489 (20%) of 2462
infants through oral medication.
Eczema, Wheeze, and Sensitization by Antibiotic Exposure
In total, 817 (32%) of 2583 infants were classified as
having had eczema in the first 2 years of life (this was
32% in the conventional and 30% in the alternative
subcohort). The incidence of recurrent wheeze was 265
(11%) of 2342 infants (12% in the conventional and 6%
in the alternative subcohort). In total, for 137 (5%) of
2546 infants, parents reported prolonged wheezing (6%
in the conventional and 4% in the alternative subco-
hort). Of infants with reported wheeze in the first 2
years, 70% had used  2-adrenergic or steroid inhalant
TABLE 1 Characteristics of Infants in the Present Study (N 2764)
Characteristic Total Cohort
n %a
Male 1410 51
Parental history of allergy
None 1339 48
Father 519 19
Mother 604 22
Both 302 11
Sibling history of allergy
No siblings 1155 44
1 sibling, not atopic 833 31
1 sibling, atopic 261 10
2 siblings, not atopic 235 9
2 siblings, 1 or both atopic 159 6
Unknown 121
Place and mode of delivery
Natural delivery at home 1179 46
Natural delivery in hospital 891 34
Artiﬁcial delivery in hospital 217 8
Cesarean section in hospital 296 12
Unknown 181
BF at 6 mo old
Yes, months 1–4 exclusive BF 622 25
Yes, months 1–4 nonexclusive BF 441 17
No, months 1–4 exclusive BF 62 3
No, months 1–4 nonexclusive 996 39
Never BF 410 16
Unknown 233
Day care in ﬁrst 6 mo
Yes 831 32
No 1724 68
Unknown 209
Pets in ﬁrst 6 mo
Yes 1168 45
No 1387 54
Unknown 209
Exposure to ETS in ﬁrst 6 mo
Yes 294 12
No 2197 88
Unknown 273
Vaccinations in ﬁrst 6 mo
By standard scheme 2242 88
By alternative schemeb 115 4
None 188 8
Unknown 219
Antibiotic exposure through BF in
ﬁrst 6 mo
Yes 262 10
No 2161 90
Unknown 341
Antibiotic exposure through oral medication
in ﬁrst 6 mo
Yes 489 20
No 1973 80
Unknown 302
Eczema in ﬁrst 2 y
Yes 817 32
No 1766 68
Unknown 181
Recurrent wheeze in ﬁrst 2 y
Yes 265 11
No 2077 89
Unknown 422
TABLE 1 Continued
Characteristic Total Cohort
n %a
Prolonged wheeze in ﬁrst 2 y
Yes 137 5
No 2409 95
Unknown 218
Allergic sensitisation at age 2 yc
Yes 223 27
No 592 72
Speciﬁc IgE against:
Hen’s egg 48 6
Cow’s milk 153 19
Peanut 42 5
Birch 7 1
Grass pollen 13 2
Cat 25 3
Dog 15 2
Mite 52 6
BF indicates breastfeeding.
a Excluding missing data.
b Delayed scheme or alternative composition of vaccine.
c Analyses conducted among infantswith blood sample (n 815). “Allergic sensitisation” refers
to1 allergen-speciﬁc IgE0.3 IU/mL.
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therapy at least once. Of infants with blood samples, 223
(27%) were sensitized against 1 allergen at 2 years old
(29% in the conventional and 24% in the alternative
subcohort).
The associations for antibiotic exposure through
breastfeeding and through medication were indepen-
dent from each other (because both were included in the
logistic regression models simultaneously). Antibiotic
exposure either through breastfeeding or directly
through medication was not associated with eczema (Ta-
ble 2). However, antibiotic exposure through breastfeed-
ing was associated with a higher risk of recurrent
wheeze (adjusted OR: 1.55; 95% CI: 1.02–2.37). This
was not found for prolonged wheeze (adjusted OR: 1.12;
95% CI: 0.62–2.02). Antibiotic exposure through med-
ication was associated with an elevated risk for recurrent
wheeze (adjusted OR: 2.65; 95% CI: 1.95–3.60) and
prolonged wheeze (adjusted OR: 2.32; 95% CI: 1.55–
3.48).
There was no association between antibiotic exposure
through breastfeeding and allergic sensitization or be-
tween antibiotic medication and allergic sensitization
(Table 2). This result remained unchanged when using a
lower cutoff point for sensitization (specific IgE 0.13
IU/mL) or when sensitization to 2 allergens was con-
sidered as the outcome (data not shown). Mean total
serum IgE level at 2 years old was not different between
infants with and without antibiotic exposure either
through breastfeeding (  .002; P  .99) or medication
(  .048; P  .80).
To exclude potential reverse causation in the associ-
ation between antibiotic exposure and wheeze, we ex-
cluded from the analyses children who wheezed in the
first half year of life (n  203 for recurrent wheeze; n 
436 for prolonged wheeze). The ORs for wheezing did
not change much compared with those in Table 2 (ad-
justed OR for recurrent wheezing: 2.18; 95% CI: 1.46–
3.25; adjusted OR for prolonged wheezing: 2.39; 95%
CI: 1.50–3.81). If we restricted our analysis to infants
who had been breastfed, the association between anti-
biotic exposure through breastfeeding and recurrent
wheeze remained unchanged (adjusted OR: 1.54; 95%
CI: 1.01–2.36).
For all outcomes, we tested the possibility of interac-
tion between antibiotic exposure and a parental history
of atopic manifestations in the multivariate analyses.
None of the tests for interaction showed a statistically
significant interaction (P always 0.10).
DISCUSSION
This prospective study shows that early antibiotic expo-
sure, both indirect through breastfeeding and direct
through oral medication, is associated with the subse-
quent development of wheezing in the first 2 years of
life. No association was found between antibiotic expo-
sure and eczema or allergic sensitization. To our knowl- T
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edge, this is the first study focusing on the association
between antibiotic exposure through breastfeeding and
the development of atopy. Our study has the advantage
of being population-based, with relatively short intervals
between subsequent follow-up questionnaires, which
decreases the possibility of recall bias. Follow-up rates
were high, which limited differential bias with regard to
baseline characteristics or outcomes.
Atopic outcomes, like infant eczema and wheeze,
may be fairly unspecific for infants aged 2 years24 and,
therefore, weak indicators of atopic development, such
as asthma in children. Children with physician-con-
firmed wheeze have been reported to have significantly
poorer lung function compared with those with only
parentally reported wheeze that was medically uncon-
firmed.25 In individuals with an atopic constitution, the
underlying mechanism of developing eczema is often
dominated by an IgE antibody-associated reaction to
specific allergens, justifying the term “atopic eczema.”
Specific IgE or total serum IgE levels are, however, only
weakly associated with atopic symptoms, like eczema
and wheeze.26 Therefore, we evaluated clinical symp-
toms and allergic sensitization as separate outcomes and
used the term eczema instead of atopic eczema. Our
definition of eczema was based on questions adapted
from the International Study of Asthma and Allergies in
Childhood questionnaires and included generally ac-
cepted characteristics, like a chronically relapsing course
and an itchy rash. Our definition of recurrent wheeze
was also based on International Study of Asthma and
Allergies in Childhood questionnaires. In addition, we
identified a second more stringent definition of wheeze
(“prolonged”), restricting it to being awake because of
wheezing in both the first and second year. In contrast to
most population-based studies, we chose to rely on par-
ents “reported symptoms” more than “doctor’s diagno-
sis” when defining outcome variables to avoid bias be-
cause of the increased likelihood of getting a doctor’s
diagnosis of asthma when parents consult a doctor for
the infant’s wheezing and get antibiotic medication (at
the same or a different occasion). In addition, parents
were asked whether medical care was provided to the
wheezing infant. This was true for 70% of wheezy in-
fants, which reinforced us to rely on the parental reports
of wheezing. Lacking information on the antibacterial
spectrum (broad versus narrow), specific indication for
which the antibiotics had been prescribed, or multiple
courses of antibiotics versus a single course represents a
limitation in our study.
Two questions arise from our findings. First, why was
antibiotic use associated with wheeze but not eczema
and allergic sensitization? Second, what are the possible
mechanisms by which antibiotic exposure increases the
risk of wheeze in infancy? We found that wheeze was
associated with antibiotic use, but eczema and sensitiza-
tion were not, and exposure through breastfeeding was
associated only with recurrent wheeze. This finding con-
tradicts the finding that antibiotics have a direct influ-
ence on the maturating immune system or affect the
development of atopic disease by preventing invasive
bacterial infections (if so, eczema and sensitization
would also be affected). The exclusive association be-
tween antibiotic use and the development of wheeze
may be because of reverse causation. It is likely that
antibiotics are prescribed because of wheezy bronchitis
and related conditions; however, this is unlikely when
considering eczema and allergic sensitization. To elimi-
nate the possibility of reverse causation, we excluded
from the analysis those infants who wheezed in the
same period (interval between questionnaires) as anti-
biotic medication had been used, thereby avoiding the
fact that symptoms preceded antibiotic prescription.
However, the association between antibiotic exposure
through breastfeeding and wheeze constitutes an argu-
ment against reverse causation. Antibiotics adminis-
trated to the infant through breastfeeding are prescribed
independently of any infant disease, because the indica-
tion is a maternal infectious episode. Two possible bio-
logical mechanisms may explain why wheeze was more
susceptible to antibiotic use than the other 2 outcome
measures, eczema and sensitization. Because of a diffi-
cult differential diagnosis in general practice between
bacterial and viral infections, antibiotics in infancy are
often prescribed for viral infections.27 Respiratory syncy-
tial virus and rhinovirus infections are strongly associ-
ated with infant wheeze in the first years of life,28 and
antibiotic use may simply be a marker for viral infec-
tions. This may only apply to young infants, because the
prospective birth cohort study of Celedon et al29 did not
show an association between antibiotic use in the first
year and wheeze in 5-year-old children.
Also, antibiotics may compromise the commensal
flora of the upper airways,30 thereby making way for
viral infections, some of which may cause later wheeze.
Simultaneously this explains why antibiotic exposure
through breastfeeding is more associated with recurrent
wheeze than prolonged wheeze. When the infant is
being compromised by maternal antibiotic use, the com-
mensal flora of the upper airways of the infant will
recover only after the mother ceases her antibiotic
course. The definition of prolonged wheeze symptoms is
the presence of wheeze in the first and second year of
infant life. It is according to the expectation that there is
no association between antibiotic use and prolonged
wheeze, because it is unlikely that mothers still breastfed
in the second year of life.
Our finding that antibiotic exposure was not associ-
ated with eczema is in agreement with previous cohort
studies,29,31 whereas some cross-sectional studies showed
positive associations.7–10 Cross-sectional studies must be
interpreted with caution. They may be subject to differ-
ential recall bias, and recall of antibiotic use may be
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linked to the reporting of atopic manifestations (report-
ing bias). Furthermore our study confirms previous re-
sults that antibiotic use was not associated with allergic
sensitization at age 2 years.29
Taken together, we demonstrated that early antibiotic
use preceded the manifestation of wheeze but not ec-
zema or allergic sensitization during the first 2 years of
life. Different biological mechanisms may underlie the
etiology of wheeze compared with eczema or sensitiza-
tion. The effect of antibiotic use through breastfeeding
on wheeze was small (OR: 2), and until further re-
search has been performed, we recommend that this
finding is replicated in other prospective studies.
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